0001714899-24-000026.txt : 20240105
0001714899-24-000026.hdr.sgml : 20240105
20240105202525
ACCESSION NUMBER: 0001714899-24-000026
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 24518052
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Watts Ryan J.
CENTRAL INDEX KEY: 0001724310
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O DENALI THERAPEUTICS INC.
STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
144
1
primary_doc.xml
144
0001724310
XXXXXXXX
LIVE
0001714899
Denali Therapeutics Inc.
001-38311
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
6508668548
Watts Ryan J.
Director
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
38th Fl.
New York
NY
10004
17483
339660.67
138385498
01/05/2024
NASDAQ
Common
01/03/2024
Restricted Stock Lapse - See Remarks
Denali Therapeutics Inc.
N
10151
01/03/2024
Equity Compensation
Common
01/04/2024
Restricted Stock Lapse - See Remarks
Denali Therapeutics Inc.
N
7332
01/04/2024
Equity Compensation
Y
Shares sold to cover tax obligation from settlement of vested Restricted Stock Units.
01/05/2024
/s/ Tyler Nielsen, by power of attorney